Literature DB >> 3410284

Does acute exposure to amiodarone prolong cardiac action potential duration?

M Aomine1.   

Abstract

1. The acute effects of a potent antiarrhythmic agent, amiodarone (AM), were studied in isolated guinea pig ventricular muscle. Transmembrane action potentials were recorded by conventional microelectrode techniques, and isometric contractile tension, by a strain gauge. 2. Short-term (30 min) exposure to 4.4 x 10(-5) M AM did not significantly effect action potential characteristics, whereas the peak developed tension was significantly depressed. 3. On the other hand, long-term (3-5 hr) exposure to the same concentration of AM led to a significant decrease in the resting membrane potential, amplitude of action potential, overshoot of action potential, maximum upstroke velocity of action potential, and the peak developed tension. However, the duration of action potential at all levels of repolarization was not significantly effected by 4.4 x 10(-5) M AM during the entire duration of the experiment. 4. These results suggest that the acute AM's antiarrhythmic actions reported may be not due to APD-lengthening action, but probably due to other actions (mainly, inhibition of Na+ channels, Ca2+ channels).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3410284     DOI: 10.1016/0306-3623(88)90173-5

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

Review 1.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

Review 2.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

3.  Acute effects of amiodarone on membrane properties, refractoriness, and conduction in guinea pig papillary muscles.

Authors:  T Maruyama; L C Richardson; W Sun; J J McCarthy; L S Gettes
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.